BioTuesdays

Category - Markets

PDS Biotechnology Logo
Markets

HCW ups PDS Biotechnology PT to $20 from $8

H.C. Wainwright raised its price target for PDS Biotechnology (NASDAQ:PDSB) to $20 from $8 ahead of additional data being released at the ASCO meeting this weekend. The stock closed at $10.86 on June 1. “We believe that...

June 2, 2021
Cutera
Markets

Cantor starts Cutera at OW; PT $55

Cantor Fitzgerald initiated coverage of Cutera (NASDAQ:CUTR) with an “overweight” rating and 12-month price target of $55. The stock closed at $40.86 on June 1. “Cutera’s comprehensive portfolio of innovative aesthetic...

June 2, 2021
Seelos Therapeutics Logo
Markets

Cantor starts Seelos Therapeutics at OW; PT $10

Cantor Fitzgerald launched coverage of Seelos Therapeutics (NASDAQ:SEEL) with an “overweight” rating and 12-to-18 month price target of $10. The stock closed at $3.08 on May 28. Analyst Charles Duncan, Ph.D., writes...

June 1, 2021
Harpoon Therapeutics
Markets

Cantor starts Harpoon Therapeutics at OW; PT $40

Cantor Fitzgerald initiated coverage of Harpoon Therapeutics (NASDAQ:HARP) with an “overweight” rating and $40 price target. The stock closed at $20.28 on May 27. Harpoon is an immunoncology company developing a next...

May 28, 2021
Corvus Pharmaceuticals
Markets

Cantor starts Corvus Pharma at OW; PT $10

Cantor Fitzgerald launched coverage of Corvus Pharmaceuticals (NASDAQ:CRVS) with an “overweight” rating and 12-month price target of $10. The stock closed at $2.66 on May 26. “We believe that the risk/reward profile is...

May 27, 2021
Chemomab-Therapeutics
Markets

Cantor starts Chemomab Therapeutics at OW; PT $45

Cantor Fitzgerald initiated coverage of Chemomab Therapeutics (NASDAQ:CMMB) with an “overweight” rating and $45 price target. The stock closed at $16.07 on May 25. Chemomab is a clinical-stage biotech company focusing...

May 26, 2021
Asensus-Surgical
Markets

HCW starts Asensus Surgical at buy; PT $4

H.C. Wainwright launched coverage of Asensus Surgical (NYSE American:ASXC) with a “buy” rating and price target of $4. The stock closed at $2.03 on May 25. Asensus, a surgical robotics company, is digitizing laparoscopy...

May 26, 2021
Vaccitech
Markets

WB starts Vaccitech at OP

William Blair initiated coverage of Vaccitech plc (NASDAQ:VACC) with an “outperform” rating. The stock was quoted at $14.35 in afternoon trading on May 25. Vaccitech is a clinical-stage biotechnology company that...

May 25, 2021
Verastem
Markets

BTIG ups Verastem to buy from neutral; PT $8

BTIG upgraded Verastem (NASDAQ:VSTM) to “buy” from “neutral” with a new price target of $8, citing a breakthrough designation from the FDA for its KRAS-focused combination therapy of VS-6766 with defactinib for all...

May 24, 2021